Altered cytochrome P450 expression in mice during pregnancy

Area of Science:

• Pharmacology
• Biochemistry
• Genetics

Background:

• Human pregnancy significantly impacts hepatic drug metabolism, primarily through cytochrome P450 (CYP) enzymes.
• The precise mechanisms driving these metabolic alterations during pregnancy are not fully understood due to a lack of suitable experimental models.

Purpose of the Study:

• To investigate the influence of pregnancy on the expression of major CYP450 isoforms in a mouse model.
• To identify specific CYP isoforms affected by pregnancy and explore potential regulatory pathways.

Main Methods:

• Liver tissues were collected from FVB/N mice at various gestational stages (prepregnancy, days 7, 14, 21, and 7 days postpartum).
• Quantitative real-time polymerase chain reaction (qPCR) was employed to determine mRNA expression levels of key CYP isoforms (Cyp1a2, Cyp2a5, Cyp2b10, Cyp2c37, Cyp2d22, Cyp2e1, Cyp3a11, Cyp3a41).

Main Results:

• Pregnancy significantly altered the expression of several CYP isoforms: Cyp3a41 expression was notably increased, while Cyp1a2, Cyp2c37, Cyp2d22, Cyp2e1, and Cyp3a11 expression decreased.
• Cyp2a5 expression remained unchanged throughout pregnancy.
• A correlation was observed between the expression of Cyp2d22 and Cyp2e1 with peroxisome proliferator-activated receptor (PPAR)α, suggesting its potential role in down-regulating these CYP isoforms during pregnancy.

Conclusions:

• Pregnancy induces significant, isoform-specific changes in hepatic CYP450 expression in mice.
• The findings suggest a potential role for PPARα in mediating the pregnancy-induced down-regulation of certain CYP isoforms.
• This study provides a foundational understanding for future research into the complex regulation of drug metabolism during pregnancy.